Shan D, Wen X, Guan X, Fang H, Liu Y, Qin M, et al
"L-Carnitine Supplementation in Recovery after Exercise." National Library of Medicine
Verbanck M, Chen CY, Neale B, Do R
3A), hence supporting our hypothesis that RSL3-induced PTC cell death is indeed a ferroptosis pathway-dependent phenomenon

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604

Key takeaways Side effects of two missed dosages can include gastrointestinal discomfort if you resume the prescription at the same dosage